The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorUniversity of Nebraska
About this trial
Investigators are studying how a device called The Lung Master device can help people breathe better. The investigational device increases the amount of air our lungs can hold, which is important for overall lung health. The Lung Master is not approved by the FDA.
The study has two visits approximately one month apart. In the first visit participants will take a spirometry test, particularly forced vital capacity (FVC), to measure volume change in the lungs. Participants will take the investigational device home to use daily, either in the morning or evening. Use will be recorded in a diary. After one month, participants will return for another spirometry test. Each study visit will take about one to two hours to complete.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
able to complete the at home portion of the study daily
fall within the age ranges: 19-35 and above 65 years old
Disqualifiers
any respiratory or chronic conditions
Trial design
Design model
Single group
Treatments tested in this trial
Lung Master (Pulmonary Exerciser)
DeviceDuring the one-month using the Lung Master at their house, the participant will be using it at least one time every day, either in the morning or in the evening before going to sleep. During the session, the participants will sit upright and try to prolong the inhalation and exhalation breaths through the Lung Master device for at least three seconds. For each session, the participants will try to concentrate on 35-50 breaths in and breaths out which is about 2-5 minutes. Every session can involve using the Pulmonary Exerciser for a minimum of 5 minutes and a maximum of 20 minutes. After each session, participants will be asked to note how long they have used the device and when they have used it. Information from each session will be recorded on the Participant Device Log that will be provided.
Treatment groups
20 Participants
are divided into 1 treatment groupGroup A: Lung Function in Young and Older AdultsExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Inspiratory Capacity
After reaching the end of a normal, quiet expiration, the maximum volume of air that can be inspired will be measured.
Time frame
baseline and after one month of device use2
Tidal Volume
The amount of air that moves in or out of the lungs with each respiratory cycle will be measured.
Time frame
baseline and after one month of device useSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov